Gender-specific markers for diagnosing prognosis and determining treatment strategies of patient of clear cell renal cell carcinoma

摘要

The present invention relates to a marker for prognostic diagnosis or a difference in the therapeutic effect of kidney cancer according to the sex of kidney cancer patients. , the mutated gene of the present invention can be used as a marker to predict a difference in the therapeutic effect of kidney cancer or the prognosis of a kidney cancer patient based on sex.